Back to Market返回行情

ATR AptarGroup, Inc.

USHealthcare
$124.45+0.19%ClosedMarket Cap: $7.94B

As of 2026-07-09 16:00

Why ATR matters now

AptarGroup, Inc. (ATR) is a US stock in Healthcare. The latest InvestLog snapshot shows $124.45 with +0.19% on the session and $7.94B in market capitalization; recent performance reads 1-month +5.91% and YTD -1.34%.

The latest financial table shown here is Q1 2026, with revenue of $982.9M, net income of $72.7M, and EPS of $1.12. Investors can compare that operating picture with valuation signals such as P/E 21.56 and FCF yield 4.2%.

The latest indexable market news headline is "Aptar Releases 2025 Corporate Sustainability Report" from Business Wire.

Additional event context on this page matters because analyst consensus is Buy with a median target of $188.00; recent insider activity includes Gandhi Aditya filing A-Award. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

21.56

PEG

4.46

P/B

2.93

P/S

1.98

EV/EBITDA

10.62

DCF Value

$184.79

FCF Yield

4.2%

Div Yield

1.6%

Margins & Returns

Gross Margin

29.0%

Operating Margin

13.0%

Net Margin

10.0%

ROE

14.3%

ROA

7.6%

ROIC

9.6%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$982.9M$72.7M$1.12
Q4 2025$962.7M$74.3M$1.13
FY 2025$3.78B$392.8M$5.88
Q3 2025$961.1M$127.9M$1.92

Analyst Ratings

Consensus

Buy

Target (Consensus)

$188.00

Target (Median)

$188.00

Target Range

$156.00 - $220.00

Strong Buy: 2Buy: 4Hold: 2Sell: 0Strong Sell: 0
Wells FargoOverweight
2026-05-04
Wells FargoOverweight
2026-03-20
Wells FargoEqual Weight
2026-01-06
BairdOutperform
2025-11-03
Wells FargoOverweight
2025-11-03

Trading Activity

Insider Trades

Gandhi Adityaofficer: CAO
Sell2026-06-16
Prieur Marcofficer: Segment President
Sell2026-06-10
Prieur Marcofficer: Segment President
Sell2026-06-10
Gandhi Adityaofficer
Sell2026-06-08
Vinczeller Shielaofficer: Chief Human Resources Officer
Sell2026-06-05

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

0.40

AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.